Semler Scientific Inc
NASDAQ:SMLR

Watchlist Manager
Semler Scientific Inc Logo
Semler Scientific Inc
NASDAQ:SMLR
Watchlist
Price: 63.65 USD -4.18% Market Closed
Market Cap: 462.7m USD
Have any thoughts about
Semler Scientific Inc?
Write Note

Net Margin
Semler Scientific Inc

27%
Current
29%
Average
2.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27%
=
Net Income
15.9m
/
Revenue
58.9m

Net Margin Across Competitors

Country US
Market Cap 453.2m USD
Net Margin
27%
Country US
Market Cap 204.9B USD
Net Margin
14%
Country US
Market Cap 195.2B USD
Net Margin
29%
Country US
Market Cap 146.7B USD
Net Margin
16%
Country US
Market Cap 132.6B USD
Net Margin
11%
Country IE
Market Cap 110.6B USD
Net Margin
12%
Country US
Market Cap 64.7B USD
Net Margin
9%
Country DE
Market Cap 55.6B EUR
Net Margin
8%
Country CN
Market Cap 319.2B CNY
Net Margin
34%
Country US
Market Cap 41.6B USD
Net Margin
74%
Country US
Market Cap 37.7B USD
Net Margin
9%
No Stocks Found

Semler Scientific Inc
Glance View

Market Cap
453.2m USD
Industry
Health Care

Semler Scientific, Inc. engages in the provision of technology and software solutions to improve the clinical effectiveness of healthcare providers. The company is headquartered in Santa Clara, California and currently employs 124 full-time employees. The company went IPO on 2014-02-27. The firm develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. The company also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The firm's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.

SMLR Intrinsic Value
17.5 USD
Overvaluation 73%
Intrinsic Value
Price

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
27%
=
Net Income
15.9m
/
Revenue
58.9m
What is the Net Margin of Semler Scientific Inc?

Based on Semler Scientific Inc's most recent financial statements, the company has Net Margin of 27%.